Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Clinical Data

AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data

 April 21, 2026

BioSpace

Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.

Clinical DataRead full story

Post navigation

MSD, Eisai report setback in first-line kidney cancer trial →
← Novo Nordisk preps filings for sickle cell drug etavopivat

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com